UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] RSS 2.0 [feed] RSS 1.0 [feed] Atom
Group by: Author | Type
Jump to: B | C | D | H | M | T
Number of items: 6.


Banerji, U; van Doorn, L; Papadatos-Pastos, D; Kristeleit, R; Debnam, P; Tall, M; ... Eskens, FA; + view all (2012) A phase I pharmacokinetic and pharmacodynamic study of CHR-3996, an oral class I selective histone deacetylase inhibitor in refractory solid tumors. Clinical Cancer Research , 18 (9) 2687 - 2694.


Corrie, P; Caplin, M; Reed, N; Qain, W; Lao-Sirieix, S-H; Hardy, R; ... Meyer, T; + view all (2012) Treatment of advanced neuroendocrine tumors: Results of the UKINETS and NCRI randomized phase II NET01 trial. In: Journal of Clinical Oncology. (pp. 4121 - ?).


Damgaard, RB; Nachbur, U; Yabal, M; Wong, WW; Fiil, BK; Kastirr, M; ... Gyrd-Hansen, M; + view all (2012) The ubiquitin ligase XIAP recruits LUBAC for NOD2 signaling in inflammation and innate immunity. Mol Cell , 46 746 - 758. 10.1016/j.molcel.2012.04.014.


Howie, AJ; (2012) Diagnosis of amyloid using Congo red. In: Picken, MM and Dogan, A and Herrera, G, (eds.) Amyloid and related disorders: surgical pathology and clinical correlations. (167 - 174). Springer: New York, USA.


Meyer, T; Fox, R; Bird, D; Watkinson, A; Hacking, N; Stocken, D; ... Palmer, DH; + view all (2012) TACE 2: A randomized placebo-controlled, double-blinded, phase III trial evaluating sorafenib in combination with transarterial chemoembolisation (TACE) in patients with unresectable hepatocellular carcinoma (HCC). In: Journal of Clinical Oncology. (pp. 4150 - ?).


Tsochatzis, EA; Meyer, T; Burroughs, AK; (2012) Hepatocellular carcinoma. N.Engl.J.Med. , 366 (1) 92 - 93. 10.1056/NEJMc1112501#SA2.

This list was generated on Sun May 24 03:53:45 2015 BST.